February 6, 2026

Semler Scientific, Inc. (SMLR) Stock Analysis: Exploring a 258.65% Potential Upside

In the dynamic world of healthcare technology, Semler Scientific, Inc. (NASDAQ: SMLR) stands as a notable contender within the medical devices industry. Headquartered in Santa Clara, California, the company is..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 17.95% Potential Upside in a Challenging Healthcare Sector

Community Health Systems, Inc. (NYSE: CYH) presents a complex investment landscape for those interested in the healthcare sector, particularly within the medical care facilities industry. As the company continues to..

Day One Biopharmaceuticals, Inc. (DAWN): A Stock with Over 116% Potential Upside – Investor Outlook

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) stands out in the biotechnology industry with its innovative approach to tackling both childhood and adult diseases. With a market capitalization of $1.08 billion,..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 67.73% Potential Upside in the Cannabis Sector

Investors looking to diversify their portfolios with a stake in the burgeoning cannabis industry might find Tilray Brands, Inc. (TLRY) an intriguing prospect. As a prominent player in the healthcare..

Claritev Corporation (CTEV) Stock Analysis: Unveiling 122.76% Potential Upside for Investors

Claritev Corporation (CTEV), a pivotal player in the healthcare sector, is drawing significant attention from investors with its compelling potential upside. With a market capitalization of $424.71 million, this U.S.-based..

Keros Therapeutics (KROS) Stock Analysis: A Promising Prospect with 36% Upside Potential

Keros Therapeutics, Inc. (NASDAQ: KROS) presents a compelling investment opportunity within the biotechnology sector, marked by a notable 36.31% potential upside, according to current analyst ratings. As a clinical-stage biopharmaceutical..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring the 10.13% Potential Upside with Strong Buy Ratings

AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the healthcare sector specializing in medical devices, is currently capturing the attention of individual investors with its innovative approach to peripheral nerve..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Exploring a 54.96% Upside Potential

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) stands out in the biotechnology sector, capturing the attention of investors with a market cap of $2.01 billion and a promising 54.96% potential upside according..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Amidst Challenging Valuations

Sonida Senior Living, Inc. (SNDA) stands as a notable player within the healthcare sector, specifically focusing on medical care facilities in the United States. With a current market capitalization of..

LifeMD, Inc. (LFMD) Stock Analysis: Discovering a Potential 233.94% Upside in the Telehealth Revolution

LifeMD, Inc. (NASDAQ: LFMD) is making waves in the healthcare sector as a direct-to-patient telehealth provider poised for significant growth. With its market cap standing at $133.34 million, LifeMD operates..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring an 83% Potential Upside in Biotech Innovation

Upstream Bio, Inc. (NASDAQ: UPB) has captured the attention of investors within the biotechnology sector, primarily due to its promising pipeline and significant potential upside. As a clinical-stage biotechnology company,..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges and Opportunities in Healthcare Staffing

AMN Healthcare Services Inc (AMN) is a prominent player in the U.S. medical care facilities industry, providing a range of workforce solutions and staffing services to healthcare institutions. With a..

Xencor, Inc. (XNCR) Stock Report: Analysts Predict 166% Upside Potential

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its robust pipeline of engineered monoclonal antibodies. As Xencor focuses on treating a variety..

Geron Corporation (GERN) Stock Analysis: Uncovering a 132.88% Potential Upside in Biotech

For investors with an appetite for high-risk and high-reward opportunities, Geron Corporation (NASDAQ: GERN) presents an intriguing case within the biotechnology sector. With its focus on oncology therapeutics, Geron is..

Ginkgo Bioworks Holdings, Inc. (DNA) Investor Outlook: Understanding the 20% Potential Upside Amidst Challenges

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the intersection of biotechnology and innovation, offering investors a glimpse into the future of cell programming. Despite a challenging market environment, the..

Kura Oncology, Inc. (KURA): Growth Potential with a 338.58% Upside and Strong Buy Ratings

Kura Oncology, Inc. (NASDAQ: KURA) stands out in the biotech sector with its promising drug pipeline aimed at tackling some of the most challenging oncological diseases. As a clinical-stage biopharmaceutical..

Embecta Corp. (EMBC) Stock Analysis: Navigating a 59% Potential Upside Amid Healthcare Innovations

Embecta Corp. (NASDAQ: EMBC), a prominent player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, is poised for an intriguing journey. With its headquarters in Parsippany,..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A 13.31% Upside with Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a key player in the specialty pharmaceutical sector, focuses on developing and commercializing innovative pain management solutions. With a market capitalization of $1.48 billion, it..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring an 88.45% Potential Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is emerging as a compelling player in the biotechnology sector, capturing the attention of investors with its promising pipeline and significant market potential. With a..

Theravance Biopharma Inc. (TBPH) Stock Analysis: Unveiling a 36% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the biotechnology sector with its promising product pipeline and strategic collaborations. With a market capitalization of $992.17 million, Theravance is a key..

Search

Funds

February 6, 2026

Search

Funds

February 6, 2026

FTSE 100

Funds